See also this year's filing and all EDGAR filings for this company.
PDF Report 0001270073_2020_Intercept_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001270073, Intercept Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 721,315,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 5,202,000 |
| 3 | remainder_Assets | 28,369,000 |
| 4 | LiabilitiesCurrent | 162,005,000 |
| 5 | LiabilitiesNoncurrent | 541,325,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 12,649,483 |
| 8 | SellingGeneralAndAdministrativeExpense | 360,523,553 |
| 9 | ResearchAndDevelopmentExpense | 257,181,251 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 444,128,629 |
| 12 | remainder_NetIncome | -34,960,715 |
| 13 | remainder_ComprehensiveNetIncome | -1,470,254 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 754,886,000 |
| 1 | Liabilities | 703,330,000 |
| 2 | Expenses | 630,354,287 |
| 3 | Revenues | 444,128,629 |
| 4 | StockholdersEquity | 51,556,000 |
| 5 | NetIncome | -221,186,373 |
| 6 | ComprehensiveNetIncome | -221,921,500 |
| 7 | BaseVar | 1,284,564,942 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.150 |
| 9 | EconomicCapitalRatio | 1.41 |
Edgar->Model Mapping
Feature Distribution
Change over Time
